| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +43.2% | -36.0% |
| R&D Expense | $2.3M | -43.8% | -32.4% |
| SG&A Expense | $1.0M | +8.3% | +19.8% |
| Operating Income | -$2.1M | +49.9% | +11.0% |
| Net Income | -$2.0M | +50.2% | +13.4% |
| EPS (Basic) | -$0.12 | +58.6% | +53.8% |
| EPS (Diluted) | -$0.12 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.6M | +68.1% | +95.5% |
| Current Assets | $21.7M | +47.2% | +99.2% |
| Total Assets | $21.7M | +47.2% | +99.2% |
| Current Liabilities | $3.3M | -21.8% | -3.3% |
| Total Liabilities | $3.3M | -21.8% | -3.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.1M | — | — |
| Financing Cash Flow | $9.9M | — | — |
| +58.6% |
| +53.8% |
| $18.4M |
| +75.3% |
| +146.8% |